Cargando…

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

Nicholas White and coauthors discuss chloroquine and hydroxychloroquine pharmacology in the context of possible treatment of SARS-CoV-2 infection.

Detalles Bibliográficos
Autores principales:	White, Nicholas J., Watson, James A., Hoglund, Richard M., Chan, Xin Hui S., Cheah, Phaik Yeong, Tarning, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Policy Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470382/ https://www.ncbi.nlm.nih.gov/pubmed/32881895 http://dx.doi.org/10.1371/journal.pmed.1003252

Ejemplares similares

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
por: Chotsiri, Palang, et al.
Publicado: (2022)

Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
por: Watson, James A., et al.
Publicado: (2023)

Concentration-dependent mortality of chloroquine in overdose
por: Watson, James A, et al.
Publicado: (2020)

Intermittent Presumptive Treatment for Malaria
por: White, Nicholas J
Publicado: (2005)

Preventing Pandemics Via International Development: A Systems Approach
por: Bogich, Tiffany L., et al.
Publicado: (2012)

Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Publicado: (2020)

The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies
por: Boni, Maciej F., et al.
Publicado: (2016)

HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention
por: Godfrey-Faussett, Peter, et al.
Publicado: (2022)

Male Circumcision for Prevention of HIV Transmission: What the New Data Mean for HIV Prevention in the United States
por: Sullivan, Patrick S, et al.
Publicado: (2007)

An Immeasurable Crisis? A Criticism of the Millennium Development Goals and Why They Cannot Be Measured
por: Attaran, Amir
Publicado: (2005)

Promoting Translational and Clinical Science: The Critical Role of Medical Schools and Teaching Hospitals
por: Dickler, Howard B, et al.
Publicado: (2006)

Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium falciparum Malaria
por: Borrmann, Steffen, et al.
Publicado: (2008)

The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
por: Cockburn, Robert, et al.
Publicado: (2005)

Will Cardiovascular Disease Prevention Widen Health Inequalities?
por: Capewell, Simon, et al.
Publicado: (2010)

HIV Treatment-as-Prevention Research at a Crossroads
por: Bärnighausen, Till, et al.
Publicado: (2014)

Criminal Justice Reform as HIV and TB Prevention in African Prisons
por: Todrys, Katherine W., et al.
Publicado: (2012)

Suicide Prevention for Older Adults in Residential Communities: Implications for Policy and Practice
por: Podgorski, Carol A., et al.
Publicado: (2010)

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment
por: Narayan, Aditya, et al.
Publicado: (2023)

Opportunities for Providing Web-Based Interventions to Prevent Sexually Transmitted Infections in Peru
por: Curioso, Walter H, et al.
Publicado: (2007)

A Surprising Prevention Success: Why Did the HIV Epidemic Decline in Zimbabwe?
por: Halperin, Daniel T., et al.
Publicado: (2011)

Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia
por: Wells, William A., et al.
Publicado: (2015)

Enrolling Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge
por: Mills, Edward, et al.
Publicado: (2006)

Europe Needs a Central, Transparent, and Evidence-Based Approval Process for Behavioural Prevention Interventions
por: Faggiano, Fabrizio, et al.
Publicado: (2014)

Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
por: Brown, Beatrice L., et al.
Publicado: (2023)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
por: Gagnon, Marc-André, et al.
Publicado: (2008)

Male Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making?
Publicado: (2009)

Improving Men’s Participation in Preventing Mother-to-Child Transmission of HIV as a Maternal, Neonatal, and Child Health Priority in South Africa
por: van den Berg, Wessel, et al.
Publicado: (2015)

Manslaughter by Fake Artesunate in Asia—Will Africa Be Next?
por: Newton, Paul N, et al.
Publicado: (2006)

Estimating the Demand for a Preventive HIV Vaccine: Why We Need to Do Better: Reliable estimates would help in achieving several policy and advocacy objectives
por: Hecht, Robert, et al.
Publicado: (2006)

Observational Evidence of For-Profit Delivery and Inferior Nursing Home Care: When Is There Enough Evidence for Policy Change?
por: Ronald, Lisa A., et al.
Publicado: (2016)

Market Failure and the Poverty of New Drugs in Maternal Health
por: Fisk, Nicholas M, et al.
Publicado: (2008)

China's Engagement with Global Health Diplomacy: Was SARS a Watershed?
por: Chan, Lai-Ha, et al.
Publicado: (2010)

Assessment of the Benefits of Targeted Interventions for Pandemic Control in China Based on Machine Learning Method and Web Service for COVID-19 Policy Simulation
por: WU, Jie Wen, et al.
Publicado: (2022)

Managing Incidental Genomic Findings in Clinical Trials: Fulfillment of the Principle of Justice
por: Dal-Ré, Rafael, et al.
Publicado: (2014)

A Survey of Public Funding of Cancer Research in the European Union
por: Eckhouse, Seth, et al.
Publicado: (2006)

Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
por: Bakare, Nyasha, et al.
Publicado: (2011)

Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Tobacco Products
por: Glantz, Stanton A., et al.
Publicado: (2009)

Who Should Pay for Global Health, and How Much?
por: Carrasco, Luis R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_33ikhcutrtdt6h72g4peohk8vo